C
Cheng Liu
Researcher at Scripps Research Institute
Publications - 29
Citations - 2407
Cheng Liu is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Legumain & Tissue factor. The author has an hindex of 19, co-authored 29 publications receiving 2280 citations.
Papers
More filters
Journal ArticleDOI
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Yunping Luo,He Zhou,Jörg Krueger,Charles D. Kaplan,Sung-Hyung Lee,Carrie S. Dolman,Dorothy Markowitz,Wenyuan Wu,Cheng Liu,Ralph A. Reisfeld,Rong Xiang +10 more
TL;DR: It is demonstrated for the first time that legumain, a member of the asparaginyl endopeptidase family functioning as a stress protein, overexpressed by TAMs, provides an ideal target molecule to suppress tumor growth and metastasis.
Journal ArticleDOI
A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas.
TL;DR: A novel murine gene, hepcarcin (hcn), encoding a 7-kb mRNA-like transcript is identified, the murine ortholog of the human alpha gene, that is, MALAT-1, consistent with a highly conserved large noncoding RNA (ncRNA).
Journal Article
Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.
TL;DR: A prodrug strategy incorporating a legumain-cleavable peptide substrate onto doxorubicin was developed and the prototype compound exhibited reduced toxicity and was effectively tumoricidal in vivo in a murine colon carcinoma model.
Journal ArticleDOI
Targeting Cell-Impermeable Prodrug Activation to Tumor Microenvironment Eradicates Multiple Drug-Resistant Neoplasms
Wenyuan Wu,Yunping Luo,Chengzao Sun,Yuan Liu,Paul C. Kuo,Janos Varga,Rong Xiang,Ralph A. Reisfeld,Kim D. Janda,Thomas S. Edgington,Cheng Liu +10 more
TL;DR: It is shown that legumain, the only asparaginyl endopeptidase of the mammalian genome, is highly expressed by neoplastic, stromal, and endothelial cells in solid tumors and thus provides new potentials for the rational development of more effective functionally targeted cancer therapeutics.
Journal Article
Prostate-specific Membrane Antigen Directed Selective Thrombotic Infarction of Tumors
Cheng Liu,Haining Huang,Fernando Donate,Craig D. Dickinson,Richard A. Santucci,Amr El-Sheikh,Robert Vessella,Thomas S. Edgington +7 more
TL;DR: It is found that the channel structures delineated by PSMA-expressing cells in human and rat prostate tumors are in functional continuity with the vasculature and thus form part of tumor microvasculature, which expands the therapeutic potential for selective infarctive ablation of tumors.